PrimeC
NST-AD-001
Phase 2 small_molecule terminated
Quick answer
PrimeC for Alzheimer Disease is a Phase 2 program (small_molecule) at NeuroSense Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- NeuroSense Therapeutics
- Indication
- Alzheimer Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated